IIM
SPRY icon

INTECH Investment Management’s ARS Pharmaceuticals SPRY Stock Holding History

INTECH Investment Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
13,249
-9,377
-41% -$89.9K ﹤0.01% 1883
2025
Q4 		$264K Sell
22,626
-8,888
-28% -$86.4K ﹤0.01% 1825
2025
Q3 		$317K Buy
31,514
+5,551
+21% +$79.7K ﹤0.01% 1799
2025
Q2 		$453K Buy
25,963
+3,616
+16% +$52.2K ﹤0.01% 1656
2025
Q1 		$281K Sell
22,347
-8,198
-27% -$98.6K ﹤0.01% 1928
2024
Q4 		$322K Buy
30,545
+14,051
+85% +$197K ﹤0.01% 1802
2024
Q3 		$239K Buy
+16,494
New +$196K ﹤0.01% 1639

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

INTECH Investment Management's SPRY Position: Q1 2026 in Review

INTECH Investment Management reduced its ARS Pharmaceuticals (SPRY) stake by 41% in Q1 2026, selling an estimated $89.9K and leaving 13,249 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

INTECH Investment Management first reported a position in SPRY in Q3 2024 and has held it in 7 quarters since. The position peaked at $453K in Q2 2025. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

  • INTECH Investment Management held 13,249 shares of ARS Pharmaceuticals worth $106K as of Q1 2026.
  • INTECH Investment Management sold 9,377 ARS Pharmaceuticals shares in Q1 2026, an estimated $89.9K.
  • ARS Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1883 holding.
  • INTECH Investment Management first reported a position in ARS Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's ARS Pharmaceuticals position peaked at $453K in Q2 2025.
  • 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.